• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome.

作者信息

Siegler R L, Milligan M K, Burningham T H, Christofferson R D, Chang S Y, Jorde L B

机构信息

Department of Pediatrics, University of Utah School of Medicine, Salt Lake City 84132.

出版信息

J Pediatr. 1991 Feb;118(2):195-200. doi: 10.1016/s0022-3476(05)80482-2.

DOI:10.1016/s0022-3476(05)80482-2
PMID:1993944
Abstract

We examined 61 patients an average of 9.6 years (range 5 to 18 years) after an episode of childhood hemolytic-uremic syndrome. Twenty-four (39%) had one or more abnormalities. Seven (11%) had proteinuria and six (10%) had low creatinine clearance as solitary abnormalities. Eight (13%) had both proteinuria and reduced creatinine clearance; three (5%) had a combination of hypertension, proteinuria, and low creatinine clearance. Abnormalities sometimes appeared after an interval of apparent recovery. Logistic regression analysis showed that duration of anuria was the best predictor of disease at follow-up. No patients who had anuria lasting longer than 8 days or oliguria exceeding 15 days escaped chronic disease. However, 45% of those with disease had no anuria, and a third had no oliguria. Physicians should therefore be cautious in assuming recovery from HUS on the basis of a single evaluation and should periodically evaluate patients for an extended period.

摘要

相似文献

1
Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome.
J Pediatr. 1991 Feb;118(2):195-200. doi: 10.1016/s0022-3476(05)80482-2.
2
Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.少尿和无尿持续时间作为腹泻后溶血尿毒综合征慢性肾脏相关后遗症的预测指标
Pediatr Nephrol. 2008 Aug;23(8):1303-8. doi: 10.1007/s00467-008-0799-9. Epub 2008 May 9.
3
Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features.阿根廷儿童溶血性尿毒症综合征:长期随访及预后特征
Pediatr Nephrol. 1997 Apr;11(2):156-60. doi: 10.1007/s004670050248.
4
Relationship of the recovery in the glomerular filtration rate to the duration of anuria in diarrhea-associated hemolytic uremic syndrome.
Am J Nephrol. 1993;13(3):194-7. doi: 10.1159/000168617.
5
Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome.既往有溶血尿毒综合征发作史的儿童的肾功能储备演变
Nephron Clin Pract. 2004;97(3):c118-22. doi: 10.1159/000078640.
6
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.腹泻相关性溶血尿毒综合征的长期肾脏预后:一项系统评价、荟萃分析和元回归分析
JAMA. 2003 Sep 10;290(10):1360-70. doi: 10.1001/jama.290.10.1360.
7
Prognostic significance of proteinuria one year after onset of diarrhea-associated hemolytic-uremic syndrome.
J Pediatr. 1991 Feb;118(2):191-4. doi: 10.1016/s0022-3476(05)80481-0.
8
Hemolytic uremic syndrome: defining the need for long-term follow-up.溶血性尿毒症综合征:明确长期随访的必要性。
Clin Nephrol. 1999 Dec;52(6):352-6.
9
Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center.加利福尼亚北部单一中心散发型溶血尿毒综合征患儿的特征。
Int Urol Nephrol. 2012 Oct;44(5):1467-72. doi: 10.1007/s11255-011-0083-y. Epub 2011 Nov 25.
10
[Prognosis of hemolytic uremic syndrome in children. Importance of extrarenal involvement].[儿童溶血尿毒综合征的预后。肾外受累的重要性]
Arch Fr Pediatr. 1986 Apr;43(4):253-8.

引用本文的文献

1
Dynamic evolution of kidney function in patients with STEC-hemolytic uremic syndrome followed for more than 15 years: unexpected changes.15 年以上随访的产志贺样毒素大肠埃希菌溶血尿毒综合征患者肾功能的动态演变:意外变化。
Pediatr Nephrol. 2025 Jan;40(1):143-150. doi: 10.1007/s00467-024-06366-w. Epub 2024 Apr 11.
2
Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up.产志贺毒素大肠埃希菌(STEC)相关性溶血尿毒综合征 10 年后的结局:长期随访的重要性。
Pediatr Nephrol. 2024 Aug;39(8):2459-2465. doi: 10.1007/s00467-024-06355-z. Epub 2024 Apr 9.
3
A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy.
一种新型的具有低免疫原性和高效力的志贺毒素 2a 中和抗体治疗药物。
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0059823. doi: 10.1128/aac.00598-23. Epub 2023 Dec 4.
4
Kidney sequelae in 281 Shiga toxin-producing Escherichia coli-hemolytic uremic syndrome patients after a median follow-up of 12 years.281 例志贺毒素产大肠埃希菌溶血尿毒综合征患者 12 年中位随访后的肾脏后遗症。
Pediatr Nephrol. 2024 Apr;39(4):1221-1228. doi: 10.1007/s00467-023-06183-7. Epub 2023 Oct 26.
5
Factors affecting dialysis duration in children with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.产志贺毒素大肠杆菌相关性溶血尿毒综合征患儿透析时间的影响因素。
Pediatr Nephrol. 2023 Aug;38(8):2753-2761. doi: 10.1007/s00467-022-05839-0. Epub 2023 Jan 27.
6
Long-term kidney outcomes in non-dialyzed children with Shiga-toxin Escherichia coli associated hemolytic uremic syndrome.非透析治疗的志贺毒素大肠杆菌相关性溶血尿毒综合征患儿的长期肾脏结局。
Pediatr Nephrol. 2023 Jul;38(7):2131-2136. doi: 10.1007/s00467-022-05851-4. Epub 2023 Jan 3.
7
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.志贺毒素相关性溶血尿毒综合征:成人患者的特点及对重症监护管理的影响。
Toxins (Basel). 2021 Apr 26;13(5):306. doi: 10.3390/toxins13050306.
8
Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency Departments.预测急诊科产志贺毒素大肠埃希菌感染的不良结局。
J Pediatr. 2021 May;232:200-206.e4. doi: 10.1016/j.jpeds.2020.12.077. Epub 2021 Jan 5.
9
Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.产志贺毒素大肠埃希菌引起的儿童溶血尿毒综合征:发病率、危险因素和临床结局。
Pediatr Nephrol. 2020 Sep;35(9):1749-1759. doi: 10.1007/s00467-020-04560-0. Epub 2020 Apr 22.
10
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.志贺毒素相关性溶血尿毒综合征:一篇叙述性综述。
Toxins (Basel). 2020 Jan 21;12(2):67. doi: 10.3390/toxins12020067.